Korro Bio, Inc. Common Stock
Symbol: KRRO (NASDAQ)
41.41
▼ (-0.07%) -0.031
Company Description:
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Key Stats
- Today's Open: $41.01
- Today's High: $42
- Today's Low: $39.015
- Today's Volume: 160.42K
- Yesterday Close: $41.44
- Yesterday High: $46.28
- Yesterday Low: $40.455
- Yesterday Volume: 198.29K
- Last Min Volume: 0
- Last Min High: $41.409
- Last Min Low: $41.409
- Last Min VWAP: $0
Company Profile
- Name: Korro Bio, Inc. Common Stock
- Website: https://www.korrobio.com
- Listed Date: 2023-11-06
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001703647
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $389.16M
- Round Lot: 100
- Outstanding Shares: 9.39M
- Asset Type: CS
RECENT FILINGS FOR KRRO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-08 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-06-18 | 8-K/A | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 8-K | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-07 | 8-K | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-01 | 4 | View |